RnRMarketResearch.com adds “Guillain-Barre Syndrome - Pipeline Review, H1 2015” to its store. This report provides an overview of the Guillain-Barre Syndrome's therapeutic pipeline.

Dallas, TX -- (SBWire) -- 06/22/2015 --The report "Guillain-Barre Syndrome - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Guillain-Barre Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Guillain-Barre Syndrome and special features on late-stage and discontinued projects.

Complete report on Guillain-Barre Syndrome with 18 market data tables and 15 figures, spread across 44 pages is available at http://www.rnrmarketresearch.com/guillain-barre-syndrome-pipeline-review-h1-2015-market-report.html

Companies discussed in this Guillain-Barre Syndrome - Pipeline Review, H1 2015 report include Alexion Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are Coversin, eculizumab, immune globulin (human), immune globulin (human), Peptide for Cholera and Guillain-Barre Syndrome.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=392694
(This is a premium report priced at US$2000 for a single user License.)

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

List of Tables
Number of Products under Development for Guillain-Barre Syndrome, H1 2015 7
Number of Products under Development for Guillain-Barre Syndrome - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Late Stage Development, H1 2015 11
Comparative Analysis by Clinical Stage Development, H1 2015 12
Comparative Analysis by Early Stage Development, H1 2015 13
Products under Development by Companies, H1 2015 14
Products under Investigation by Universities/Institutes, H1 2015 15
Guillain-Barre Syndrome - Pipeline by Alexion Pharmaceuticals, Inc., H1 2015 16
Guillain-Barre Syndrome - Pipeline by Takeda Pharmaceutical Company Limited, H1 2015 17
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Stage and Target, H1 2015 20
Number of Products by Stage and Mechanism of Action, H1 2015 22
Number of Products by Stage and Route of Administration, H1 2015 24
Number of Products by Stage and Molecule Type, H1 2015 26
Guillain-Barre Syndrome Therapeutics - Recent Pipeline Updates, H1 2015 35
Guillain-Barre Syndrome - Dormant Projects, H1 2015 42

List of Figures
Number of Products under Development for Guillain-Barre Syndrome, H1 2015 7
Number of Products under Development for Guillain-Barre Syndrome - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Late Stage Development, H1 2015 11
Comparative Analysis by Clinical Stage Development, H1 2015 12
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Top 10 Targets, H1 2015 19
Number of Products by Stage and Top 10 Targets, H1 2015 20
Number of Products by Top 10 Mechanism of Actions, H1 2015 21
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Top 10 Routes of Administration, H1 2015 23
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 24
Number of Products by Top 10 Molecule Types, H1 2015 25
Number of Products by Stage and Top 10 Molecule Types, H1 2015 26

Explore more reports on Therapeutics at
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics

About RnRMarketResearch.com
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.